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Introduction
Live-cell imaging is a powerful analytical tool yielding 
information about the kinetics of biological processes or 
compound activity and allows for discrimination between 
primary and secondary phenotypes to correctly determine 
their mode of action. Nevertheless, most high-content 
screening assays are end-point assays as live-cell imaging is 
generally considered more challenging in high-throughput 
than fixed-cell imaging. Some examples of added difficul-
ties of live-cell screening are maintaining sterile culture 
conditions, bleaching/phototoxicity issues during imaging, 
and devising schemes for adding compounds across many 
plates in a synchronous fashion to the acquisition to ensure 
equal incubation times across all wells. Therefore, only a 
few live-cell screens have been reported to date.1–4 Never-
theless, imaging screens are in some aspects easier to per-
form with live cells compared with fixed cells since neither 
fixing nor washing is required, thereby streamlining robotic 
workflows and reducing variability.
We took the challenge to bring an assay tracking subcel-
lular objects to a medium-throughput assay. We developed 
an assay measuring the dynamics of late endosomes labeled 
with LAMP1-GFP in U-2 OS cells. LAMP1 is concentrated 
on late endosomes and lysosomes (Suppl. Fig. S1).5–7 This 
assay is amenable to screen several thousands of com-
pounds and offers deeper insight into the mode of action of 
compounds compared with a fixed-cell assay. Here we pres-
ent methods on how to optimize the settings for automated 
microscopy with live cells, add compounds in a nearly syn-
chronous fashion to all wells, and analyze the resulting 
images to extract quantitative information about vesicle 
movement. We show that the kinetic parameters add critical 
dimensionality, allowing better phenotypic clustering than 
using static parameters only. Thanks to kinetic parameters, 
we identified a group of compounds from the family of car-
diac glycosides, which increase the motion of endosomes. 
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Abstract
Automated imaging screens are performed mostly on fixed and stained samples to simplify the workflow and increase 
throughput. Some processes, such as the movement of cells and organelles or measuring membrane integrity and potential, 
can be measured only in living cells. Developing such assays to screen large compound or RNAi collections is challenging in 
many respects. Here, we develop a live-cell high-content assay for tracking endocytic organelles in medium throughput. We 
evaluate the added value of measuring kinetic parameters compared with measuring static parameters solely. We screened 
2000 compounds in U-2 OS cells expressing Lamp1-GFP to label late endosomes. All hits have phenotypes in both static 
and kinetic parameters. However, we show that the kinetic parameters enable better discrimination of the mechanisms 
of action. Most of the compounds cause a decrease of motility of endosomes, but we identify several compounds that 
increase endosomal motility. In summary, we show that kinetic data help to better discriminate phenotypes and thereby 
obtain more subtle phenotypic clustering.
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All the other compounds have the opposite phenotype, lead-
ing to decreased movement of endosomes.
Materials and Methods
Cell Culture
U-2 OS cells were grown in RPMI 1640 Glutamax media 
with phenol red (cat. 61870; Invitrogen, Carlsbad, CA) sup-
plemented with 10% fetal calf serum (FCS) (cat. P282710; 
PAN, Aidenbach, Germany) and 50 μg/mL gentamicin (cat. 
15750-037; Invitrogen). U-2 OS cells with Lamp1-GFP 
growth medium was supplemented with 200μg/ml G418 
(Cat. 10131-35, Invitrogen).
For experiments in microtiter plates, cells were first 
stained by adding Hoechst 33342 (cat. H21492; Invitrogen) 
at a final concentration of 2 μg/mL to a cell culture flask for 
30 min. After incubation, cells were washed twice with phos-
phate-buffered saline (PBS), dissociated with 0.05% trypsin 
(cat. 25300-054; Invitrogen) for 3 min, counted with the 
CASY counter (Scharfe System, Reutlingen, Germany), and 
seeded at 4000 cells per well in 30 μL RPMI 1640 without 
phenol red (cat. 32404; Invitrogen), supplemented with 2 
mM L-glutamine (cat. 25030; Invitrogen), 25 mM HEPES 
(cat. 15630-049; Invitrogen), 50 μg/mL gentamicin, and 10% 
FCS into a 384-well imaging plate (cat. 781092; Greiner Bio-
One, Monroe, NC). Prior to acquisition, 40 μL of mineral oil 
(cat. M8410; Sigma, St. Louis, MO) was added to each well 
to eliminate evaporation during acquisition.
Chemical Library and Layout
We screened the Spectrum Collection library from MicroSource 
Discovery (Gaylordsville, CT). This library contains approxi-
mately 2000 biologically active and structurally diverse com-
pounds. Columns 2, 3, 4 and 23 contain negative and positive 
controls and untreated samples. Negative control was DMSO 
(cat. 276855; Sigma), and positive control was 5 μM 
nocodazole (cat. M1404; Sigma) in DMSO. The library was 
distributed in seven 384-well plates and screened at 10 μM in 
0.1% DMSO final concentration.
Image Acquisition
Control movies to determine sampling parameters were 
acquired on an Olympus IX71 inverted wide-field micro-
scope with an Olympus UApo/340—40×/0.9 objective 
(Olympus, Tokyo, Japan) and equipped with an Andor iXon 
EM DU 897_BV back-illuminated EMCCD camera (Andor, 
Belfast, Northern Ireland). This camera has 512 × 512 pixels, 
with a pixel size of 16 μm. With 40× lens and 2× optovar, 
the image pixel size is 0.2 μm.
All other images were acquired on an automated micro-
scope (BD Biosciences Pathway 855; BD Biosciences, San 
Jose, CA) equipped with a live-cell chamber, using an 
Olympus UApo/340—40×/0.90 objective with the filter 
sets shown in Supplementary Table S1.
The pixel size of the CCD camera was 6.45 μm. We 
acquired images with a binning of 2, resulting in 0.323 μm/
pixel.
Image Analysis
The image analysis was performed with the freely available 
in-house developed software MotionTracking (http://
motiontracking.mpi-cbg.de/get/).
Image correction. We acquired reference images after each 
acquisition to correct images in a preprocessing step. The 
correction function is composed of a linear affine transfor-
mation (translation, rotation, projection) and a nonlinear 
spline fit for fine adjustment.8
The background is estimated with a simple mean filter 
with a kernel size approximately four times the size of the 
objects to be detected. The resulting image is then sub-
tracted from the original.
In fluorescence microscopy, the predominant noise is the 
photon counting noise that follows a Poisson distribution 
and whose amplitude is proportional to the signal intensity. 
Linear models can be used to estimate noise amplitude as a 
function of the pixel intensity to weigh each pixel according 
to its information value.9
Image quantification. Segmentation of objects was achieved 
by fitting Lorenzian functions to find nuclei and endosomes, 
allowing determining intensity and shape parameters with 
high precision at a subpixel resolution.10 The cells were seg-
mented with an active contour algorithm on the combined 
image of the endosome and nuclear channel.11 Static param-
eters were extracted from the segmented endosomes and 
nuclei.
For tracking, we used information about endosomal 
position, intensity, and shape to search locally for the best 
candidate for linking objects between frames.12 From the 
endosome tracks, we extracted kinetic parameters such as 
endosome speed, processivity, and displacement.
Data Analysis
Image analysis data were further processed with MATLAB 
from MathWorks (Natick, MA). Out-of-focus movies (low 
nuclei contrast and gradient intensity on the object edges) and 
movies containing either less than 3 or more than 35 cells 
were removed from analysis. Movies were considered outli-
ers and removed if one of their measurements was more than 
4 standard deviations (SD) away from the population mean 
within the same condition and the same plate. The parameters 
of the remaining movies were normalized by applying a 
platewise z score normalization to DMSO.13,14 The median of 
the z scores per well was then computed. In live-cell 
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imaging, compounds are not removed before imaging and 
autofluorescent compounds can be problematic. Compounds 
yielding either nuclear Hoechst fluorescence more than 10 
SD or GFP Lamp1 fluorescence more than 4 SD from DMSO 
were considered autofluorescent. Compounds were consid-
ered toxic if their volume-weighted Hoechst nuclear intensity 
was 3 SD above DMSO and the ratio of the cell to nuclei 
areas was 4 SD above DMSO. Autofluorescent and toxic 
compounds were removed from the hit list and not used for 
validation screen. For hierarchical clustering, Z score values 
were length normalized onto the unit hypersphere.
Principal component analysis and hierarchical clustering 
were performed in open-source programming language R, 
version 2.14.0 and following versions (R Foundation for 
Statistical Computing, Vienna, Austria). Some graphs were 
produced using the ggplot2 library.
Parameters. Twenty-three of 96 measured Lamp1 parame-
ters were chosen for analysis based on three criteria: (1) a 
Pearson correlation coefficient among parameters below 
0.8 (absolute mean 0.225), (2) a Pearson correlation coeffi-
cient between runs above 0.8, and (3) a heuristic that param-
eters representing all categories (intensity, morphology, 
location, kinetic) should be present. Furthermore, nuclei 
intensity morphology was measured. A point in an endo-
some track is called “processive” if it is followed by three 
consecutive points that fall between two rays forming an 
angle of 30 degrees, drawn from the first point. Subsequent 
points classified as “processive” form subsets of endosome 
tracks that are defined as processive movement events. A 
list with parameter names and their respective IDs is 
included in Table 1.
Results
Establishing the Lamp1-GFP Cell Line
To develop our endosome tracking assays, we established a 
stable cell line expressing a Lamp1-GFP construct under 
the control of the cytomegalovirus (CMV) promoter (see 
supplementary materials and Falcon-Perez et al.15).
Determination of Image Acquisition Parameters
To estimate our required sampling rate and to establish a 
minimal observation time, we first determined the speed of 
the Lamp1-GFP labeled endosomes. We acquired control 
movies at frame rates ranging from 2 to 30 frames per sec-
ond (fps) for 60 s on a wide-field inverted microscope 
equipped with a fast back-illuminated EMCCD camera. We 
calculated the mode of the speed of endosomes for different 
frame rates of the control movies (Fig. 1A).
Another factor besides speed of objects influencing the 
necessary frame rate for tracking is the distance between 
objects. Densely distributed objects require faster frame 
rates compared with more sparse objects, as the distance 
traveled by an object between two frames can more readily 
exceed the object-to-object distance, potentially causing 
errors in object linking between frames. We therefore mea-
sured the nearest neighbor distances between objects (Fig. 
1B) and estimated the maximum speed from a single movie.
We chose the mean of the nearest neighbor distance dis-
tribution divided by the maximum speed to obtain the frame 
rate (equation 1).
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We determined that the maximal acquisition rate of the 
ORCA-ER CCD camera of our screening microscope at bin-
ning 2 was approximately 4.5 fps. Given the experimentally 
measured endosome speed and density, we determined that 
we were able to capture approximately 75% of all tracks but 
were not able to track the fastest events accurately.
To accurately estimate the kinetic parameters of objects, 
one needs to sufficiently sample them in time. We therefore 
aimed to establish the minimal number of images per movie 
necessary to obtain stable readouts. Several movies of 30 s 
length were acquired at the maximal frame rate of 4.5 fps. 
We calculated the mode of endosome speed for the entire 
sequences and shorter subsets to obtain different sampling 
intervals. The sampling interval yielding the minimal dif-
ference between the maximum deviation of individual mea-
surements and the mean measurement for each movie was 
determined (Fig. 1C). These calculations resulted in a mini-
mum movie length of 15 s with 68 images per movie. To 
have a safety margin, we decided to acquire 80 images per 
movie (approximately 19 s).
A further important setting is the exposure time of each 
image, since it determines the signal-to-noise ratio. We cre-
ated a set of artificial images designed to resemble actual 
cells with a known number of cell objects and artificial 
endosomes with variable intensities and variable signal-to-
noise ratios. We then tested our image-processing software 
and set a minimal threshold detection accuracy of 95% to 
determine the lowest acceptable signal-to-noise ratio. A 
similar signal-to-noise ratio was attained in our images with 
exposure times of 150 ms.
The minimal observation time, signal-to-noise ratio, and 
acquisition speed determine an acquisition parameter space, 
where the image analysis can be performed meaningfully. The 
observation time, signal-to-noise ratio, and acquisition speed 
are controlled on the microscope by setting the number of 
frames, exposure time, and the frame rate, respectively (see 
Fig. 1D). These constraints need to be respected when opti-
mizing other assay parameters such as cell viability.
Last, a single image of the Hoechst-stained nuclei was 
acquired per field of view to estimate directionality of endo-
some movement, estimate compound toxicity, and focus 
(1)
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quality. The concentration of Hoechst was optimized to obtain 
reliable segmentation without inducing cell death, and cells 
were imaged with a 380/10-nm pass band filter with a 50% 
neutral density filter to reduce UV exposure (see Materials and 
Methods). To obtain a sufficient number of cells per condition 
for analysis, we acquired four movies per well.
Once the minimal acquisition parameters are deter-
mined, it is important to verify that cell viability is unaf-
fected under those conditions. We compared the growth and 
survival of stained and imaged cells with unstained and 
nonimaged cells and showed that cell numbers were unaf-
fected (data not shown). The light-induced damage induced 
by our acquisition conditions is therefore tolerable to cells 
and can be used for screening. In summary, for our screen, 
we determined that we could acquire four movies per well 
with 80 images at an excitation wavelength of 488/10 nm, 
an exposure time of 150 ms, and a frame rate of 4.5 images 
per second and 1 image at an excitation wavelength of 
380/10 nm, a 50% neutral density filter, and an exposure 
time of 50 ms.
Assay Validation
Endosomes are moved by molecular motors along the tubu-
lin and actin cytoskeleton. The tubulin network is essential 
for fast and directed movement and can be dissociated by 
microtubule depolymerizing agents such as nocodazole.16,17
To validate our acquisition parameters and experimental 
setup, U-2 OS cells were treated with increasing concentrations 
of nocodazole ranging from 0.4 to 10 μM and the kinetic 
Table 1. Complete Names of All Measured Parameters and Their Corresponding Parameter ID.
Parameter ID Parameter Name
 1 Mean Speed (Channel 1) ColorVesiculeSet Weighted=FALSE CalcType = Mean
 2 Mean of Max. Displacement (Channel 1) ColorVesiculeSet Weighted=FALSE CalcType = Mean
 3 Mean of Max. Displacement (Channel 1) ColorVesiculeSet Weighted=TRUE WeightingFunc=GetVolume 
CalcType = Mean
 4 Mean Processive Movement (Channel 1) ColorVesiculeSet Weighted=TRUE WeightingFunc=GetMeanIntensity 
CalcType = Mean
 5 Mean of Processive to Total Time Ratio (Channel 1) ColorVesiculeSet Weighted=FALSE CalcType = Mean
 6 Mean of Processive to Total Time Ratio (Channel 1) ColorVesiculeSet Weighted=TRUE 
WeightingFunc=GetVolume CalcType = Mean
 7 Integ. Ves. Intens. (Channel 1) ColorVesiculeSet Mask = TRUE
 8 MeanIntCH1
 9 MeanIntCH1VolWeig
10 MeanIntegIntCH1
11 MeanAreaCH1
12 Mean Anisotropy In Cells (Channel 1) ColorVesiculeSet Weighted=FALSE WeighingFunc=GetVolume 
ExcludeBorder=TRUE Normalize Size=TRUE CalcType = Mean
13 Dist. Distr. (Channel 1) ColorVesiculeSet Min. Distance=0.5 Max. Distance=30 Weighted=FALSE 
WeighingFunc=GetVolume Param 1
14 Integ. Ves. Intens. (Channel 2) ColorVesiculeSet Mask = TRUE
15 MeanIntegIntCH2
16 MeanIntegIntCH2VolWeig
17 MeanElongationCH2
18 Per Cell Frame Intens. (Channel 1) ColorVesiculeSet Intensity=Total NormalizeCellArea=TRUE Print To 
File=FALSE CalcType = Mean
19 Numb. Ves. per Cell (Channel 1) ColorVesiculeSet Mask = TRUE Print To File=FALSE CalcType = Mean
20 Dist. to Nucl. Cell Based (Channel 1) ColorVesiculeSet Weighted=FALSE WeighingFunc=GetVolume 
Normalization=None CalcMethod=DistToNuc CalcType = Mean
21 Dist. to Nucl. Per Cell (Channel 1) ColorVesiculeSet Weighted Vesicules=FALSE WeighingFuncVes=GetVolume 
Weighted Cells=FALSE WeightingCellMethod=GetVolume Normalized=TRUE NormalizingFactor=NucleusSize 
Print To File=FALSE CalcType = Mean
22 Dist. to Nucl. Per Cell (Channel 1) ColorVesiculeSet Weighted Vesicules=FALSE WeighingFuncVes=GetVolume 
Weighted Cells=FALSE WeightingCellMethod=GetVolume Normalized=TRUE NormalizingFactor=CellArea 
Print To File=FALSE CalcType = Mean
23 Contact Ratio ColorVesiculeSet Weighted=FALSE WeighingFunc=GetVolume Min Radius Pixel=5 Print To 
File=FALSE Exclude Border Objects=TRUE ToCalculate=ContactRatio CalcType = Mean
Parameters 1 to 6 are kinetic; 7 to 23 are static.
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parameters of vesicles were measured (see Fig. 2A). Average 
endosome speed was reduced with increasing concentrations of 
nocodazole, reaching a minimum at 3.5 μM. We calculated the 
IC50 values of 23 parameters and the Mahalanobis distance
18 of 
all parameters between DMSO and nocodazole. Most parame-
ters had IC50 values below 5 μM; the IC50 of the Mahalanobis 
distance was 5 μM (see Fig. 2B). We decided to use 5 μM 
nocodazole as a control during the screen. Example videos of 
untreated cells, DMSO-treated cells, and nocodazole-treated 
cells with the tracking of the objects can be seen in 
Supplementary Videos S1, S2, and S3, respectively.
Primary Screen of MSD Chemical Library
We screened the MSD Spectrum Collection library com-
prising 2000 compounds arrayed in seven 384-well plates 
using our optimized acquisition parameters. The acquisition 
of a well requires 1 min, 30 s; a column of 16 wells requires 
24 min; an entire 384-well plate requires 9 h, 30 min; and 
the acquisition of all seven plates requires over 66 h.
Thus, compounds cannot be added simultaneously to all 
plates as the last well of the last plate would be incubated 
for 66 h longer than the first well of the first plate. The 
screen therefore needed to be carried out one plate at a time. 
A similar incubation problem arises within a plate since the 
acquisition of an entire plate requires 9.5 h. To solve this 
problem, we added the compounds column-wise every 24 
min, which corresponded to the time required for the micro-
scope to acquire a column. By acquiring the images 
column-wise, the incubation difference between the first 
and last wells was 24 min, and the compound addition 
required 9.5 h. The plate was imaged 4 h following the last 
compound addition. In this way, each well was incubated 
for approximately 14 h, and each plate was screened on a 
separate day. A further DMSO-only plate was screened to 
increase the robustness of the statistics. The entire screen 
took approximately a month to perform and generated 
12,288 movies. A schematic workflow of the screen can be 
seen in Supplementary Figure S2. The images were ana-
lyzed, outliers removed, and the data normalized plate-wise 
to the DMSO control (see Materials and Methods).
Multivariate Z factors19 for six plates were between 0.77 
and 0.87, indicating strong phenotypic responses. One plate 
showed low multivariate Z factor and was discarded from 
further analysis. The data were filtered for outliers, toxicity, 
and autofluorescent compounds (see Materials and 
Methods). For 247 compounds, tracking failed due to either 
focus problems or clumping of the objects, and the data 
Figure 1. Optimization of parameters for kinetic acquisition of endosome movement. (A) The mode vesicle speed is plotted as a 
function of the acquisition time per frame. The curve shows a plateau on the left-hand side indicating that from an acquisition time 
of 0.1 s (frame rate of 10 frames per second), most vesicles can be tracked successfully. (B) Nearest neighbor distance distribution, 
measured between the endosomes. (C) The maximum difference of the average vesicle speed measured for several movies to the 
mean measurement is plotted as a function of observation time. Each point is calculated on a set of four movies. The maximum 
deviation is used to reflect variability between similar measurements. When decreasing, it indicates reproducibility. The curve 
reveals the minimum movie duration to consistently measure the endosome speed. (D) Acquisition space: the gray cube delimits the 
acquisition space (possible values of parameter and their combination) for the critical parameter observation time, frame rate, and 
image signal-to-noise (SNR) ratio.
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were not further analyzed. In total, 1452 compounds could 
be successfully analyzed. The pairwise Pearson correlation 
coefficient between the multiparametric profiles of the 
nocodazole controls on different plates was on average 0.8, 
indicating that the assay was highly reproducible. The cell 
counts were not significantly different between positive and 
negative controls, indicating that nocodazole had not caused 
cells to detach.
Compounds were classified as active based on their 
Mahalanobis distance from DMSO.18–21 We chose a 
Mahalanobis distance of 13 as a cutoff since it was the half-
way distance between the highest untreated control (11.13) 
and the lowest of the nocodazole control (14.9) (Fig. 3A). 
Our selected cutoff was very stringent as neither DMSO or 
untreated false positives nor nocodazole false negatives 
were selected. This cutoff selected 79 compounds out of 
1452 reagents (5.4%). The normalized well-averaged data 
are shown in Supplementary Table S2.
Next, we performed hit confirmation with 73 of 79 hits 
in duplicate. Not all primary hits were tested in the reconfir-
mation, because a previous analysis (data not shown) had 
identified a slightly different subset of compounds, and hit 
picking had been carried out based on a common list. Forty-
eight compounds showed in both duplicates a Mahalanobis 
distance greater than the highest Mahalanobis distance of 
the untreated control, resulting in a 65.7% reconfirmation 
rate (Fig. 3B). Forty-eight compounds showed a Pearson 
correlation coefficient above 0.6 between replicate runs and 
were therefore considered robust and reconfirmed 
(reconfirmation rate of 65.7%). The normalized well-aver-
aged data are shown in Supplementary Table S3.
Clustering of Confirmed Hits
Next, we analyzed the phenotypes of our hit compounds. All 
compounds showed both a static and a kinetic phenotype, 
and none of the identified compounds would have been 
missed in a nonkinetic screen. This was to be expected since 
changes in exchange rates between donor and acceptor com-
partments would most likely lead to morphological changes 
in those compartments. We performed hierarchical clustering 
of the hit phenotypes using the cosine as a distance measure. 
To estimate the importance of the kinetic data for distinguish-
ing phenotypes, clustering was carried out with (Suppl. Fig. 
S2) and without (Suppl. Fig. S3) kinetic parameters. Most 
compounds resulted in decreased endosome motility, but a 
small cluster showed increased speed and displacement of 
endosomes (see cluster delimited by green box in Suppl. Fig. 
S2). This cluster contains oleandrin, digitoxin, digoxin, and 
neriifolin, all of which belong to the class of cardiac glyco-
sides. These compounds do not cluster together clearly with-
out kinetic parameters. We performed also clustering around 
medoids to confirm this result. Silhouette analysis of the data 
set without the kinetic parameter suggested an optimum of 
17 clusters.22 With 17 clusters, the four cardiac glycosides 
did not cluster together, but with the kinetic parameter, they 
formed a distinct cluster (Suppl. Tables S4 and S5, 
respectively). Next, we performed principal component 
Figure 2. Assay validation on nocodazole-treated cells. (A) Probability density plot of endosome speed, with endosome speed on 
the x-axis and number of endosomes on the y-axis. Each color represents a different nocodazole concentration. The peak of the 
speed distributions is maximally left shifted at 0.9 μM. (B) IC50 curve of the Mahalanobis distance between DMSO and the various 
concentrations of nocodazole. The Mahalanobis distance is calculated from all parameters, including parameters not influenced by 
nocodazole such as nuclear Hoechst intensity. The blue line connects Mahalanobis distances for each concentration; the red line is a 
four-parameter logistic regression fit curve for IC50.
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analysis (PCA) to estimate the contribution of the kinetic 
parameters to the clustering results. Kinetic parameters con-
tributed largely to principal components 1 and 2 (Fig. 4A). 
Kinetic parameter 3 (maximum displacement) showed the 
strongest contribution to principal component 2, with a 
Pearson correlation between principal component 2 and 
kinetic parameter 3 of –0.8 (Fig. 4B). Thus, kinetic parame-
ters have an important contribution to the clustering result.
As the results of hierarchical clustering can depend on 
multiple parameter choices, we also performed an addi-
tional, independent test not relying on the clustering of the 
phenotypes. Chemically similar compounds can in many 
cases be expected to induce similar phenotypes and there-
fore show a lower phenotypic distance. We computed the 
Tanimoto similarities between hit compounds using 2D 
chemical fingerprints from the Chemistry Development 
Kit.23 A group of 19 chemical pairs was observed to be 
clearly more similar to each other than the other compound 
pairs with Tanimoto distances between 0.74 and 1 versus 
less than 0.61 for others (annotated with color blocks in 
Suppl. Fig. S4). We then compared pairwise phenotypic 
Euclidian distances between similar and dissimilar com-
pound pairs. As predicted, on average, the distances were 
smaller between similar compounds than between similar 
and dissimilar compounds. The difference between the dis-
tances of both groups can be expected to increase for more 
accurate phenotypic descriptors. We tested the difference of 
distances between the two groups with a one-sided 
Kolmogorov-Smirnov test. The distance was greater and bet-
ter with all parameters, including the kinetic parameters (p = 
4e-5) compared with the static parameters only (p = 2.5e-4) 
(see Suppl. Fig. S4). In summary, the kinetic parameters 
allow a more precise phenotypic clustering of distinguishing 
compounds, causing an increase in kinetic parameters com-
pared with compounds reducing kinetic parameters. The 
clustering with kinetic parameters was more consistent with 
the clustering of the chemical structures.
Discussion
Our aim was to develop a high-content assay measuring the 
kinetic parameters of endosomal movement, with emphasis on 
going beyond the more commonly measured static parameters, 
such as morphology and intensity. The efforts to develop, carry 
out, and analyze the screen were considerable and in our expe-
rience much more difficult than for a conventional screen with 
fixed cells. First, object tracking requires the optimization of 
acquisition parameters, such as frame rate and movie length, 
that is not required for fixed assays. This optimization requires 
a suite of experiments where cells are imaged at a different 
frame rate and for long periods and the survival of the cells 
under optimized conditions is verified. Second, the throughput 
of the assay is massively reduced due to the time required to 
add compounds in a synchronized fashion and to acquire a 
plate. With our equipment and protocol, the acquisition of a 
single 384-well plate requires 10 h of recording. This imposes 
a compound addition time of 10 h, and therefore a single plate 
per day can maximally be acquired. The throughput could be 
increased with additional microscopes or a much faster micro-
scope with a larger camera chip but would still be much lower 
than a conventional fixed-cell screen. Third, incubation condi-
tions are not ideal in a microscope. This is particularly true for 
the BD Pathway 855, which does not have humidity control. 
We circumvented evaporation problems by covering the wells 
with mineral oil and using CO2 independent medium to com-
pensate the diminished gas exchange. Fourth, the image analy-
sis to segment all frames of the movies and link the objects 
between frames is challenging and computationally demand-
ing. The computational costs are dependent on the software, 
the desired precision of the analysis, and the hardware 
Figure 3. Boxplots with Mahalanobis distance per group of treatment. (A) Mahalanobis distance was calculated for each well from all 
parameters for the primary screen. (B) Mahalanobis distance was calculated for each well from all parameters for the reconfirmation 
screen. DMSO-treated wells were used as a reference in both cases. MSD represents library compound–treated wells.
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available at the time of analysis. Our software, Motion 
Tracking, segments and tracks objects with high precision and 
requires correspondingly large computational resources. The 
processing time of a single 384-well plate required 43,000 
CPU hours and was carried out on a 2500 CPU cluster farm of 
the Technische University of Dresden.
Thus, live-cell screens tracking numerous and fast 
objects are challenging, and the benefits of obtaining kinetic 
parameters must be carefully evaluated in light of the 
increased effort and costs involved.
Our analysis shows that the kinetic parameters did not con-
tribute to the detection of hit phenotypes. Therefore, in our 
case, a large chemical screen could and should be carried out 
using fixed cells. Furthermore, our analysis showed that kinetic 
parameters contribute critical additional information for clus-
tering of hit compounds. The kinetic parameters allow two 
classes of compounds to be distinguished: those that decrease 
and those that increase the motility of endosomes. The static 
morphological changes do not result in a clear distinction 
between these two classes. A further indication that the use of 
kinetic parameters is beneficial for phenotypic clustering is 
that the phenotypic clustering results are more consistent with 
the chemical clustering when including the kinetic parameters. 
Thus, even though our kinetic assay would not be amenable to 
a large compound screen, it is of great value for classifying 
compounds that would emerge from such a screen. In general, 
increasing the number of relevant and orthogonal parameters 
to measure cellular phenotypes allows more granular resolu-
tion of phenotypes and therefore better clustering.
Our kinetic analysis allowed us to distinguish a class of 
compounds that increased the kinetic parameters such a 
speed and processivity. All compounds belong to the family 
of cardiac glycosides, whose primary mode of action is the 
inhibition of Na+/K+ ATPases. Rosen et al.24 have previ-
ously shown that cardiac glycosides had a profound effect 
on endocytosis and that transferrin accumulated in large 
perinuclear vesicles positive for Rab7 and Rab11 but nega-
tive for low-density lipoprotein. This effect was mediated 
directly by Na+/K+ ATPase activity. It was proposed that the 
cardiac glycosides alter the activity of Na+/K+ pump in 
endosomes, thereby increasing the acidification of endo-
somes.25 The phenotype induced by the cardiac glycosides 
in U-2 OS cells appears to be different from the one reported 
by Rosen and coworkers. In some cells, large perinuclear 
vesicles can be observed, but the majority of cells have 
small, fast-moving Lamp1-GFP vesicles. The differences 
might be due to differences in cell lines, different concen-
tration of drugs, or incubation time. At this stage, we cannot 
speculate as to the reasons for observed increased move-
ment of Lamp1 endosomes in response to cardiac glyco-
sides. Cardiac glycosides have been reported to have 
pleiotropic effects, affecting many cellular pathways26; in 
particular, nonreceptor tyrosine kinase c–Src has been 
reported to be activated in response to binding to Na+/K+ 
pumps. Src family kinases have been implicated in regulat-
ing endosomal trafficking through control of distinct Rho 
family GTPases and the actin cytoskeleton.27 Src associates 
with early endosomes containing RhoD and with late endo-
somes containing RhoB.28,29 Thus, it is possible that the 
increased motility of late endosomes upon treatment with 
cardiac glycoside is a result of the activation of c-Src and 
the activation of RhoD containing late endosomes.
Figure 4. Principal component analysis. (A) Plot showing loading of each parameter onto principal component 1 (PC1) on the x-axis 
and principal component 2 (PC2) on the y-axis. Kinetic parameters are represented with a normal line and static parameters with 
dotted line. This indicates that kinetic parameters 1, 5, and 6 greatly contribute to PC1, and kinetic parameters 2, 3, and 4 contribute 
greatly to PC2. (B) Scatter plot of kinetic parameter 3 and PC2 showing high anticorrelation. Pearson correlation is –0.8. Cardiac 
glycoside compounds are marked as black triangles.
8
ht
tp
://
do
c.
re
ro
.c
h
Here we bring clear evidence that a kinetic screen 
improves phenotypic clustering of hit compounds and 
brings more insight into their modes of action. Due to the 
low throughput, this kind of assay is not suitable for pri-
mary screens but can be added to the secondary assay pipe-
lines and hit confirmations.
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